Metformin Inhibits Monocyte-to-Macrophage Differentiation via AMPK-Mediated Inhibition of STAT3 Activation: Potential Role in Atherosclerosis
The DOI matches its Crossref record; 32 of the 32 references it cites were found in a registry or an index.
Abstract
Monocyte-to-macrophage differentiation is a critical event that accentuates atherosclerosis by promoting an inflammatory environment within the vessel wall. In this study, we investigated the molecular mechanisms responsible for monocyte-to-macrophage differentiation and, subsequently, the effect of metformin in regressing angiotensin II (Ang-II)-mediated atheromatous plaque formation in ApoE−/− mice. AMPK activity was dose and time dependently downregulated during phorbol myristate acetate (PMA)-induced monocyte-to-macrophage differentiation, which was accompanied by an upregulation of proinflammatory cytokine production. Of note, AMPK activators metformin and AICAR significantly attenuated PMA-induced monocyte-to-macrophage differentiation and proinflammatory cytokine production. However, inhibition of AMPK activity alone by compound C was ineffective in promoting monocyte-to-macrophage differentiation in the absence of PMA. On the other hand, inhibition of c-Jun N-terminal kinase activity inhibited PMA-induced inflammation but not differentiation, suggesting that inflammation and differentiation are independent events. In contrast, inhibition of STAT3 activity inhibited both inflammation and monocyte-to-macrophage differentiation. By decreasing STAT3 phosphorylation, metformin and AICAR through increased AMPK activation caused inhibition of monocyte-to-macrophage differentiation. Metformin attenuated Ang-II–induced atheromatous plaque formation and aortic aneurysm in ApoE−/− mice partly by reducing monocyte infiltration. We conclude that the AMPK-STAT3 axis plays a pivotal role in regulating monocyte-to-macrophage differentiation and that by decreasing STAT3 phosphorylation through increased AMPK activity, AMPK activators inhibit monocyte-to-macrophage differentiation.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“A working model of metformin’s anti-inflammatory properties also suggests that metformin, in an AMPK-dependent inhibition of STAT3, prevents the differentiation of monocytes to macrophages”
From Benefits of Metformin in Attenuating the Hallmarks of Aging (2020) · cites this paper as Vasamsetti et al. 2015
Citations
Cites
1 retracted
Activation of Protein Phosphatase 2A by Palmitate Inhibits AMP-activated Protein Kinase
Wu, Y., Song, P., Xu, J., Zhang, M., & Zou, M.-H. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m608310200 · Cited by 274 · cited 1×
“AMPK-mediated signaling events are downregulated by lipopolysaccharides (LPSs), free fatty acids, high-fat diets, and lipid infusion in macrophages and endothelial cells (12,13).”
BackgroundRetractedRole of AMP-Activated Protein Kinase in Mechanism of Metformin Action
Zhou, G., Myers, R., Li, Y., Chen, Y., Shen, X., Fenyk-Melody, J., Wu, M., Ventre, J., Doebber, T., Fujii, N., et al. (2001) · Journal of Clinical Investigation · doi:10.1172/jci13505 · Cited by 5,652 · cited 1×
“Earlier studies showed that the pleiotropic effects of metformin are partly mediated by the activation of AMPK (7,8).”
BackgroundAMPK: a nutrient and energy sensor that maintains energy homeostasis
Hardie, D. G., Ross, F. A., & Hawley, S. A. (2012) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3311 · Cited by 4,602 · cited 2×
“AMPK functions as a fuel gauge, sensing the changes in the energy status of the cell and, thus, playing a critical role in regulating systemic energy balance (9,10).”
BackgroundKahn, B. B., Alquier, T., Carling, D., & Hardie, D. G. (2005) · Cell Metabolism · doi:10.1016/j.cmet.2004.12.003 · Cited by 2,799 · cited 1×
“AMPK functions as a fuel gauge, sensing the changes in the energy status of the cell and, thus, playing a critical role in regulating systemic energy balance (9,10).”
BackgroundMacrophages in the Pathogenesis of Atherosclerosis
Moore, K. J., & Tabas, I. (2011) · Cell · doi:10.1016/j.cell.2011.04.005 · Cited by 2,669 · cited 3×
“a diverse repertoire of inflammatory mediators (2).”
BackgroundThe immune response in atherosclerosis: a double-edged sword
Hansson, G. K., & Libby, P. (2006) · Nature Reviews Immunology · doi:10.1038/nri1882 · Cited by 2,182 · cited 3×
“Substantial evidence implicates that macrophages are abundantly present at all stages of atherosclerotic disease process (1).”
InfluentialPPARγ Promotes Monocyte/Macrophage Differentiation and Uptake of Oxidized LDL
Tontonoz, P., Nagy, L., Alvarez, J. G. A., Thomazy, V. A., & Evans, R. M. (1998) · Cell · doi:10.1016/s0092-8674(00)81575-5 · Cited by 1,797
Steinberg, G. R., & Kemp, B. E. (2009) · Physiological Reviews · doi:10.1152/physrev.00011.2008 · Cited by 1,637 · cited 1×
“AMPK activity in the blood is predominantly located in monocytes and lymphocytes as the 1a isoform (25), and a reduction in AMPK activity is associated with various pathophysiological effects (26).”
Background
Cited by
Items 101–200 of 431
Jin, Z. G., Li, J., Pi, J., Chu, Q., Wei, W., Du, Z., Qing, L., Zhao, X., & Wu, W. (2020) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2020.110015 · Cited by 68
Novel pharmacological approaches in abdominal aortic aneurysm
Puertas-Umbert, L., Almendra‐Pegueros, R., Jiménez‐Altayó, F., Sirvent, M., Galán, M., Martínez‐González, J., & Rodríguez, C. (2023) · Clinical Science · doi:10.1042/cs20220795 · Cited by 68
Macrophage iron dyshomeostasis promotes aging‐related renal fibrosis
Wu, L., Lin, H., Li, S., Huang, Y., Sun, Y., Shu, S., Luo, T., Liang, T., Lai, W., Rao, J., et al. (2024) · Aging Cell · doi:10.1111/acel.14275 · Cited by 67
“…such as caloric restriction and the use of metabolically targeted drugs, including metformin, resveratrol, and rapamycin, have been shown to impact longevity by influencing the macrophage population (Fabbiano et al., 2016; Minhas et al., 2021 ; van Beek et al., 2019; Vasamsetti et al., 2015 ).”
Shi, R., Wang, J., Zhang, Z., Leng, Y., & Chen, A. F. (2023) · Life Sciences · doi:10.1016/j.lfs.2022.121339 · Cited by 56
Bakrim, S., Fessikh, M. E., Elhrech, H., Omari, N. E., Amanullah, M. R., Ming, L. C., Moshawih, S., & Bouyahya, A. (2025) · Journal of Translational Medicine · doi:10.1186/s12967-025-06583-3 · Cited by 66
“…myeloid cell leukemia-1; MCL1, myeloid cell leukemia-1; HIF-1α, hypoxia-inducible factor 1α; mSTAT3, mitochondrial signal transducer and activator of transcription 3 to inhibit monocyte differentiation into macrophages via AMP-activated protein kinase (AMPK)-mediated STAT3 dephosphorylation [179].”
Role of AMPK in atherosclerosis via autophagy regulation
Ou, H.-X., Liu, C., Feng, W., Xiao, X., Tang, S., & Mo, Z. (2018) · Science China Life Sciences · doi:10.1007/s11427-017-9240-2 · Cited by 66
Dattani, N., Sayers, R. D., & Bown, M. J. (2018) · Diabetes and Vascular Disease Research · doi:10.1177/1479164118780799 · Cited by 65
Fung, C. S. C., Wan, E. Y. F., Wong, C. K. H., Jiao, F., & Chan, A. K. C. (2015) · Cardiovascular Diabetology · doi:10.1186/s12933-015-0304-2 · Cited by 63
Wu, P., Yan, Y., Ma, L., Hou, B., He, Y., Zhang, L., Niu, Z., Song, J.-K., Pang, X.-C., Yang, X., et al. (2016) · Journal of Biological Chemistry · doi:10.1074/jbc.m115.712703 · Cited by 64
Metformin inhibits ROS production by human M2 macrophages via the activation of AMPK
Nassif, R. M., Chalhoub, E., Chedid, P., Hurtado-Nedelec, M., Raya, E., Dang, P. M.-C., Marie, J.-C., & El-Benna, J. (2022) · Biomedicines · doi:10.3390/biomedicines10020319 · Cited by 63
“showed that metformin inhibited monocyte to M1 differentiation via AMPK [56].”
BackgroundLi, B., Po, S. S., Zhang, B., Bai, F., Li, J., Qin, F., Liu, N., Sun, C., Xiao, Y., Tu, T., et al. (2020) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.15407 · Cited by 63
Karnewar, S., Vasamsetti, S. B., Gopoju, R., Kanugula, A. K., Ganji, S. K., Prabhakar, S., Rangaraj, N., Tupperwar, N., Kumar, J. M., & Kotamraju, S. (2016) · Scientific Reports · doi:10.1038/srep24108 · Cited by 62
Self-citationCardiovascular Protection by Metformin: Latest Advances in Basic and Clinical Research
Li, J. Z., & Li, Y. R. (2023) · Cardiology · doi:10.1159/000531432 · Cited by 62
Osman, I., & Segar, L. (2015) · Biochemical Pharmacology · doi:10.1016/j.bcp.2015.11.026 · Cited by 62
Malik, R. A., Zippel, N., Frömel, T., Heidler, J., Zukunft, S., Walzog, B., Ansari, N., Pampaloni, F., Wingert, S., Rieger, M. A., et al. (2016) · Circulation Research · doi:10.1161/circresaha.116.309937 · Cited by 62
Gopoju, R., Panangipalli, S., & Kotamraju, S. (2018) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2018.02.031 · Cited by 61
Self-citationMolecular mechanisms of action of metformin: latest advances and therapeutic implications
Zhu, H., Jia, Z., Li, Y. R., & Danelisen, I. (2023) · Clinical and Experimental Medicine · doi:10.1007/s10238-023-01051-y · Cited by 61
“Metformin suppresses atherosclerosis in animal models via AMPK activation [33, 34].”
BackgroundContext-Dependent Pharmacological Effects of Metformin on the Immune System
Marcucci, F., Romeo, E. L., Caserta, C. A., Rumio, C., & Lefoulon, F. (2020) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2020.01.003 · Cited by 61
Metformin and its therapeutic applications in autoimmune inflammatory rheumatic disease
Kim, J., Choe, J., & Park, S. (2021) · The Korean Journal of Internal Medicine · doi:10.3904/kjim.2021.363 · Cited by 60
“Furthermore, AMPK-dependent inhibition of STAT3 and nuclear factor kappa-light-chain-enhancer of activated B cells (NF-κBs) pathways are involved in the inhibition of monocyte-to-macrophage differentiation, and reduce the production of inflammatory cytokines by macrophages [24,25].”
BackgroundHuang, S., Chyuan, I., Shiue, C., Yu, M., Hsu, Y., & Hsu, M. (2020) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.14879 · Cited by 60
Seneviratne, A. N., Cave, L., Hyde, G. D., Moestrup, S. K., Carling, D., Mason, J. C., Haskard, D. O., & Boyle, J. J. (2020) · Cardiovascular Research · doi:10.1093/cvr/cvaa171 · Cited by 61
“In Apoe mice with infusions of Ang-II that induced aortic aneurysms, metformin suppressed aneurysm formation.(45) In Apoe mice fed a high-fat diet, metformin and other AMPK-activators suppressed peripheral monocyte count.”
BackgroundWu, K., Tian, R., Huang, J., Yang, Y., Dai, J., Jiang, R., & Zhang, L. (2018) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2018.05.018 · Cited by 59
Zhang, Y., Wang, H., & Xiao, H. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22095016 · Cited by 59
Metformin prescription and aortic aneurysm: systematic review and meta-analysis
Yu, X., Jiang, D., Wang, J., Wang, R., Chen, T., Wang, K., Durgahee, M. S. A., Wei, X., & Cao, S. (2019) · Heart · doi:10.1136/heartjnl-2018-314639 · Cited by 57
Therapeutic Effects of STAT3 Inhibition on Experimental Murine Dry Eye
Qu, M., Qi, X., Wang, Q., Wan, L., Li, J., Li, W., Li, Y., & Zhou, Q. (2019) · Investigative Opthalmology & Visual Science · doi:10.1167/iovs.19-26928 · Cited by 54
Macrophage polarization and signaling in diabetic kidney disease: a catalyst for disease progression
Youssef, N., Noureldein, M. H., Riachi, M. E., Haddad, A., & Eid, A. A. (2023) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00266.2023 · Cited by 56
Reprogram to heal: Macrophage phenotypes as living therapeutics
Ghamangiz, S., Jafari, A., Maleki, H., Azimi, H., & Mazloomi, E. (2025) · Life Sciences · doi:10.1016/j.lfs.2025.123601 · Cited by 56
Elzahhar, P. A., Alaaeddine, R. A., Ibrahim, T. M., Nassra, R. A., Ismail, A. E., Chua, B. S. K., Frkic, R. L., Bruning, J. B., Wallner, N., Knape, T., et al. (2019) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2019.02.034 · Cited by 56
Mechanisms of cancer cell killing by metformin: a review on different cell death pathways
Wu, X., Xu, W., Huan, X., Wu, G., Li, G., Zhou, Y., & Najafi, M. (2022) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-022-04502-4 · Cited by 56
Unosson, J., Wågsäter, D., Bjarnegård, N., Basso, R. D., Welander, M., Mani, K., Gottsäter, A., & Wanhainen, A. (2020) · Annals of Vascular Surgery · doi:10.1016/j.avsg.2020.06.039 · Cited by 55
“…and AAA growth rate among those with metformin prescription along with the large number of cytokines lower expressed suggests a broad effect of metformin to reduce inflammation and extracellular matrix remodeling 11,17 and a possible mechanism whereby metformin may reduce the AAA growth rate.”
Metabolic and Molecular Mechanisms of Macrophage Polarisation and Adipose Tissue Insulin Resistance
Orliaguet, L., Ejlalmanesh, T., & Alzaïd, F. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21165731 · Cited by 58
“Metformin inhibits differentiation of monocytes to macrophages through AMPK-mediated inhibition of STAT3, which also resulted in decreased monocyte infiltration into atherosclerotic plaques and an ameliorated outcome in mice [65].”
BackgroundKong, G., Zhou, L., Serger, E., Palmisano, I., Virgiliis, F. D., Hutson, T. H., McLachlan, E., Freiwald, A., Montanara, P. L., Shkura, K., et al. (2020) · Nature Metabolism · doi:10.1038/s42255-020-0252-3 · Cited by 54
Justice, J. N., Gubbi, S., Kulkarni, A. S., Bartley, J. M., Kuchel, G. A., & Barzilai, N. (2020) · GeroScience · doi:10.1007/s11357-020-00261-6 · Cited by 53
“Metformin improves the immune response and reduces inflammation by promoting the formation of M2 macrophages and T regulatory and CD8 memory T cells [56], and may prevent the differentiation of monocytes to macrophages via an AMPKdependent inhibition of STAT3 [57].”
BackgroundGonzález‐López, P., Álvarez‐Villarreal, M., Ruiz‐Simón, R., López‐Pastor, A. R., de Céniga, M. V., Esparza, L., Martín-Ventura, J. L., Escribano, Ó., & Gómez‐Hernández, A. (2023) · Clinical and Translational Medicine · doi:10.1002/ctm2.1363 · Cited by 53
Lin, F., Song, C., Zeng, Y., Li, Y., Li, H., Liu, B., Dai, M., & Pan, P. (2020) · International Immunopharmacology · doi:10.1016/j.intimp.2020.106969 · Cited by 53
Sadik, N. A., Rashed, L. A., & Abd‐Elmawla, M. A. (2021) · International Journal of General Medicine · doi:10.2147/ijgm.s295939 · Cited by 52
Anti-Cancer Stem-like Cell Compounds in Clinical Development – An Overview and Critical Appraisal
Marcucci, F., Rumio, C., & Lefoulon, F. (2016) · Frontiers in Oncology · doi:10.3389/fonc.2016.00115 · Cited by 51
Luo, C., Lian, X., Hong, L., Zou, J., Li, Z., Zhu, Y., Huang, T., Zhang, Y., Hu, Y., Yuan, H., et al. (2016) · Cellular Physiology and Biochemistry · doi:10.1159/000452567 · Cited by 51
Ma, C., Zhang, W., Yang, X., Liu, Y., Liu, L., Feng, K., Zhang, X., Yang, S., Sun, L., Yu, M., et al. (2018) · British Journal of Pharmacology · doi:10.1111/bph.14156 · Cited by 48
“Several animal studies also indicate that metformin can inhibit atherosclerosis but only in the context of diabetes (Li et al., 2011; Forouzandeh et al., 2014; Hayashi et al., 2014; Wang et al., 2017).”
BackgroundImmune dysfunction in developmental programming of type 2 diabetes mellitus
Golden, T., & Simmons, R. A. (2021) · Nature Reviews Endocrinology · doi:10.1038/s41574-020-00464-z · Cited by 51
Thanigaimani, S., Singh, T. P., Unosson, J., Phie, J. K. P., Moxon, J. V., Wanhainen, A., & Golledge, J. (2021) · European Journal of Vascular and Endovascular Surgery · doi:10.1016/j.ejvs.2021.06.013 · Cited by 50
Zhao, X., Ren, T., Li, S., Wang, X., Hou, R., Guan, Z., Liu, D., Zheng, J., & Shi, M. (2024) · International Journal of Biological Sciences · doi:10.7150/ijbs.99680 · Cited by 48
Gao, J., Zhao, J., Zhu, H., Peng, X., Zhu, J.-X., Ma, M., Fu, Y. S., Hu, N., Tai, Y., Xuan, X., et al. (2018) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2018.06.020 · Cited by 48
Savarese, G., Butler, J., Lund, L. H., Bhatt, D. L., & Anker, S. D. (2021) · Cardiovascular Research · doi:10.1093/cvr/cvab271 · Cited by 48
Yang, Q., Yuan, H., Chen, M., Qu, J., He, W., Yu, B., Chen, J., Sun, S., Tang, X., & Ren, W. (2018) · Life Sciences · doi:10.1016/j.lfs.2018.02.017 · Cited by 47
Jiang, L., Dong, J., Ren, Y., Zhu, J., Cao, J., Zhang, J., & Pan, L. (2018) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2018.6499 · Cited by 47
Effect of AMPK signal pathway on pathogenesis of abdominal aortic aneurysms
Yang, L. J., Shen, L., Gao, P., Li, G., He, Y., Wang, M., Zhou, H., Yuan, H., Jin, X., & Wu, X. (2017) · Oncotarget · doi:10.18632/oncotarget.21608 · Cited by 45
Yan, Z., Tian, X., Zhu, J., Lu, Z., Yu, L., Zhang, D., Liu, Y., Yang, C., Zhu, Q., & Cao, X. (2018) · Molecular Medicine · doi:10.1186/s10020-018-0013-x · Cited by 44
Zhou, R., Ding, R.-C., Qian, Y., Qiu, C.-Z., Zhang, H., Yin, Z., & Ren, D. (2024) · Antioxidants · doi:10.3390/antiox13020176 · Cited by 44
“It dampens cytokine production in macrophages and lymphocytes [8,9] and inhibits the NF-κ B signaling pathway [10].”
BackgroundNamgaladze, D., Snodgrass, R. G., Angioni, C., Grossmann, N., Dehne, N., Geißlinger, G., & Brüne, B. (2015) · Journal of Biological Chemistry · doi:10.1074/jbc.m115.678243 · Cited by 44
“and inhibition of STAT3 by metformin during monocyteto-macrophage differentiation of THP-1 cells (33).”
BackgroundHao, B., Xiao, Y., Song, F., Long, X., Huang, J., Tian, M., Deng, S., & Wu, Q. (2017) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2017.3346 · Cited by 41
“The mechanism of action of metformin in atherosclerosis is associated with AMPK (29,30).”
RetractedThe phosphatase PPM1A controls monocyte-to-macrophage differentiation
Smith, S. R., Schaaf, K., Rajabalee, N., Wagner, F., Duverger, A. E., Kutsch, O., & Sun, J. (2018) · Scientific Reports · doi:10.1038/s41598-017-18832-7 · Cited by 43
Elkhatib, M. A. W., Mroueh, A., Rafeh, R. W., Sleiman, F., Fouad, H. H., Saad, E. I., Fouda, M. A., Elgaddar, O., Issa, K., Eid, A. H., et al. (2019) · Translational research · doi:10.1016/j.trsl.2019.07.009 · Cited by 43
Sun, J. L., El‐Aty, A. M. A., Jeong, J. H., & Jung, T. W. (2020) · The American Journal of Chinese Medicine · doi:10.1142/s0192415x20500469 · Cited by 43
Pulipaka, S., Singuru, G., Sahoo, S., Shaikh, A., Thennati, R., & Kotamraju, S. (2023) · GeroScience · doi:10.1007/s11357-023-01015-w · Cited by 43
“In line with this, previously, we showed that Mito-Esc and metformin by activating AMPK improve and manifest downstream effects [13, 17, 20].”
Self-citationNeeli, P. K., Gollavilli, P. N., Mallappa, S., Hari, S. G., & Kotamraju, S. (2019) · Oncogene · doi:10.1038/s41388-019-1126-6 · Cited by 42
Self-citationExploring the Correlation and Protective Role of Diabetes Mellitus in Aortic Aneurysm Disease
Arun, D., Munir, W., Schmitt, L. V., Vyas, R., Ravindran, J. I., Bashir, M., Williams, I. M., Velayudhan, B. V., & Mohammed Idhrees, A. (2021) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2021.769343 · Cited by 43
AMPK activation reduces the number of atheromata macrophages in ApoE deficient mice
Wang, J., Ma, A., Zhao, M. F., & Zhu, H. (2017) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2017.01.036 · Cited by 42
Luo, F., Guo, Y., Ruan, G., Long, J., Zheng, X., Qin, X., Zhao, S., Peng, D., Fang, Z., & Li, X. (2017) · Scientific Reports · doi:10.1038/s41598-017-02080-w · Cited by 41
Petrie, J. R., Chaturvedi, N., Ford, I., Hramiak, I., Hughes, A. D., Jenkins, A. J., E. Klein, B., Klein, R., Ooi, T. C., Rossing, P., et al. (2017) · Diabetes, Obesity and Metabolism · doi:10.1111/dom.12840 · Cited by 39
“bition of STAT3 (and thereby monocyte to macrophage differentiation) in vascular tissue.(31) Moreover, metformin can inhibit advanced glycosylation end product (AGE) formation by binding and inactivating methyglyoxal via an AMPK-independent pathway.”
Transcriptional control of macrophage polarisation in type 2 diabetes
Drareni, K., Gautier, J., Venteclef, N., & Alzaïd, F. (2019) · Seminars in Immunopathology · doi:10.1007/s00281-019-00748-1 · Cited by 40
“bition of STAT3; this also resulted in decreased monocyte infiltration into atherosclerotic plaques and an ameliorated outcome in mice [18].”
BackgroundThe regulation effect of AMPK in immune related diseases
Wang, J., Li, Z., Gao, L., Qi, Y., Zhu, H., & Qin, X. (2017) · Science China Life Sciences · doi:10.1007/s11427-017-9169-6 · Cited by 39
Relationship between metformin and abdominal aortic aneurysm
Raffort, J., Hassen‐Khodja, R., Jean‐Baptiste, E., & Lareyre, F. (2019) · Journal of Vascular Surgery · doi:10.1016/j.jvs.2019.08.270 · Cited by 39
Zhang, H., Zhangsun, Z., Xue, C.-X., Li, X.-Y., Ren, J. T., Jiang, Y., Liu, T., Yao, H.-R., Zhang, J., Gou, T.-T., et al. (2022) · Acta Pharmacologica Sinica · doi:10.1038/s41401-022-00991-7 · Cited by 39
“Lipidloaded macrophages are involved in almost all stages of plaque development and progression, which expressing scavenger receptors, taking up high ox-LDL particles and leading to foam cell formation [91, 92].”
BackgroundYang, X., Ma, Y., Chen, X., Zhu, J., Xue, W., & Ning, K. (2023) · Life Sciences · doi:10.1016/j.lfs.2023.121867 · Cited by 39
Icariin inhibits atherosclerosis progress in Apoe null mice by downregulating CX3CR1 in macrophage
Wang, Y., Wang, Y., Song, S.-L., Liang, H., & Ji, A. (2016) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2016.01.118 · Cited by 39
AMPK/Mitochondria in Metabolic Diseases
Bullón, P., Marín‐Aguilar, F., & Román-Malo, L. (2016) · Proceedings of the Fourth International Symposium on Polarization Phenomena in Nuclear Reactions · doi:10.1007/978-3-319-43589-3_6 · Cited by 38
Immunometabolic Changes in Glia – A Potential Role in the Pathophysiology of Obesity and Diabetes
Robb, J. L., Morrissey, N. A., Potter, P. G. W., Smithers, H. E., Beall, C., & Ellacott, K. L. J. (2019) · Neuroscience · doi:10.1016/j.neuroscience.2019.10.021 · Cited by 37
“, 2016), some of which are linked to a role in modulating cellular metabolism (Vasamsetti et al., 2015).”
Mbara, K. C., Mato, P. E. M., Driver, C., Nzuza, S., Mkhombo, N. T., Gcwensa, S. K., Mcobothi, E. N., & Owira, P. M. O. (2021) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2021.173934 · Cited by 36
Tai, Y., Li, L., Peng, X., Zhu, J.-X., Mao, X.-H., Qin, N., Ma, M., Huo, R., Bai, Y., & Dong, D. (2018) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2018.07.010 · Cited by 36
Monocytes as a convergent nanoparticle therapeutic target for cardiovascular diseases
Aldarondo, D., & Wayne, E. C. (2022) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2022.114116 · Cited by 36
Sui, Q., Hu, Z., Liang, J., Lu, T., Bian, Y., Jin, X., Li, M., Huang, Y., Yang, H., Wang, Q., et al. (2023) · Cancer Letters · doi:10.1016/j.canlet.2023.216497 · Cited by 36
PAQR11 modulates monocyte‐to‐macrophage differentiation and pathogenesis of rheumatoid arthritis
Lin, Y., Huang, M., Wang, S., You, X., Zhang, L., & Chen, Y. (2021) · Immunology · doi:10.1111/imm.13303 · Cited by 35
Effect of Metformin on Cardiac Metabolism and Longevity in Aged Female Mice
Zhu, X., Shen, W., Liu, Z., Sheng, S., Xiong, W., He, R., Zhang, X., Ma, L., & Ju, Z. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2020.626011 · Cited by 35
“Metformin (Met) was initially introduced for the treatment of type II diabetes mellitus in 1957, which has been then found salutary in reducing cardiovascular mortality and morbidity (Vasamsetti et al., 2015; Bergmark et al., 2019).”
MethodKang, K., Xia, A., Meng, F., Chunyu, J., Sun, X., Ren, G., Yu, D., Jiang, X., Tang, L., Xiao, W. L., et al. (2021) · International Immunopharmacology · doi:10.1016/j.intimp.2021.107634 · Cited by 35
Baradaran, Z., Vakilian, A., Zare, M., Hashemzehi, M., Hosseini, M., Dinpanah, H., & Beheshti, F. (2021) · Behavioural Brain Research · doi:10.1016/j.bbr.2021.113399 · Cited by 35
Golledge, J., Arnott, C. G., Moxon, J. V., Monaghan, H., Norman, R., Morris, D., Li, Q., Jones, G. T., Roake, J., Bown, M. J., et al. (2021) · Trials · doi:10.1186/s13063-021-05915-0 · Cited by 35
Ma, M., Li, F., Li, W., Zhao, H., Jiang, M., Yu, Y., Dong, Y., Zhang, Y., Li, P., Bu, W., et al. (2022) · British Journal of Pharmacology · doi:10.1111/bph.15949 · Cited by 35
“Since AMPK activation and STAT3 inhibition suppress neointimal hyperplasia, we examined the effect of nitazoxanide and tizoxanide on serum- (15% FBS) and PDGF-BB-induced proliferation of A10 cells.”
BackgroundInfluentialYounis, A., Eskenazi, D., Goldkorn, R., Leor, J., Naftali-Shani, N., Fisman, E. Z., Tenenbaum, A., Goldenberg, I., & Klempfner, R. (2017) · Cardiovascular Diabetology · doi:10.1186/s12933-017-0551-5 · Cited by 32
AMPK integrates metabolite and kinase-based immunometabolic control in macrophages
Phair, I. R., Nisr, R. B., Howden, A. J. M., Sovakova, M., Alqurashi, N., Foretz, M., Lamont, D., Viollet, B., & Rena, G. (2022) · Molecular Metabolism · doi:10.1016/j.molmet.2022.101661 · Cited by 34
Shan, K., Qu, H., Zhou, K., Wang, L., Zhu, C., Chen, H., Gu, Z., Cui, J., Fu, G., Li, J., et al. (2019) · mSystems · doi:10.1128/msystems.00219-19 · Cited by 34
Hu, Y., Xu, R., He, Y., Zhao, Z., Mao, X., Lin, L., & Hu, J. (2020) · Molecular Medicine Reports · doi:10.3892/mmr.2020.11147 · Cited by 34
“Firstly, only STaT3 was selected to investigate further due to its association with atherosclerosis development via the regulation of cell apoptosis and inflammation, and because it is a target of miR‐106a‐5p (52); it would be useful to study other targets of mir-106a-5p.”
BackgroundInfluentialHuman Aging and Age-Related Diseases: From Underlying Mechanisms to Pro-Longevity Interventions
Chmielewski, P. P., Data, K., Strzelec, B., Farzaneh, M., Anbiyaiee, A., Zaheer, U., Uddin, S., Sheykhi-Sabzehpoush, M., Mozdziak, P. E., Zabel, M., et al. (2024) · Aging and Disease · doi:10.14336/ad.2024.0280 · Cited by 35
Development of pharmacotherapies for abdominal aortic aneurysms
Weaver, L. M., Loftin, C. D., & Zhan, C. (2022) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2022.113340 · Cited by 33
Dihoum, A., Rena, G., Pearson, E. R., Lang, C. C., & Mordi, I. R. (2023) · Expert Opinion on Investigational Drugs · doi:10.1080/13543784.2023.2196010 · Cited by 33
Metformin: Sentinel of the Epigenetic Landscapes That Underlie Cell Fate and Identity
Menéndez, J. A. (2020) · Biomolecules · doi:10.3390/biom10050780 · Cited by 33
“Additionally, there are several examples of the metabolic ability of metformin to facilitate (or impede) the transition from one cell type to another, including neuronal [52–54], osteogenic [55–58], adipogenic [39,59], myofibroblast and myoblast [60,61] differentiation, or monocyte-to-macrophage differentiation [62],…”
BackgroundEl-Haggar, S. M., Hegazy, S. K., Maher, M., Bahgat, M. M., & Bahaa, M. M. (2024) · International Immunopharmacology · doi:10.1016/j.intimp.2024.112541 · Cited by 32
Dietary Restriction and Oxidative Stress: Friends or Enemies?
Mladenović, A., Lončarević‐Vasiljković, N., & Gonos, E. S. (2020) · Antioxidants and Redox Signaling · doi:10.1089/ars.2019.7959 · Cited by 30
“In addition to this well-known role, it has been shown that metformin possesses both direct and indirect antioxidant properties (102, 140, 160, 177, 188), with the activation of AMPK pathways being the main mechanisms for its effects.”
Cellular Mechanisms of Inflammaging and Periodontal Disease
Clark, D. L., Radaic, A., & Kapila, Y. L. (2022) · Frontiers in Dental Medicine · doi:10.3389/fdmed.2022.844865 · Cited by 30
Yuan, Z., Heng, Z., Lü, Y., Wei, J., & Cai, Z. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2021.721213 · Cited by 29
Salminen, A. (2023) · Biogerontology · doi:10.1007/s10522-023-10072-9 · Cited by 30
“For instance, Vasamsetti et al. (2015) demonstrated that metformin and AICAR treatments inhibited the differentiation of monocytes into macrophages and accordingly, metformin attenuated the Ang-II-induced formation of atherosclerotic lesions in mice.”
BackgroundHuangfu, N., Wang, Y., Cheng, J., Xu, Z., & Wang, S. (2018) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2018.5704 · Cited by 29
“In addition, metformin could inhibit monocyte-to-macrophage differentiation via AMPK-mediated inhibition of STAT3 activation, which may play an important role in atherosclerosis (35).”
The Role of AMPK/mTOR Modulators in the Therapy of Acute Myeloid Leukemia
Višnjić, D., Dembitz, V., & Lalić, H. (2018) · Current Medicinal Chemistry · doi:10.2174/0929867325666180117105522 · Cited by 29
Neeli, P. K., Sahoo, S., Karnewar, S., Singuru, G., Pulipaka, S., Annamaneni, S., & Kotamraju, S. (2022) · FEBS Journal · doi:10.1111/febs.16605 · Cited by 28
Self-citationJansen, T., Kröller‐Schön, S., Schönfelder, T., Foretz, M., Viollet, B., Daiber, A., Oelze, M. W., Brandt, M., Steven, S., Kvandová, M., et al. (2018) · Cardiovascular Research · doi:10.1093/cvr/cvy172 · Cited by 28
Turkistani, A. A., Al‐kuraishy, H. M., Al-Gareeb, A. I., Alexiou, A. T., Papadakis, M., Bahaa, M. M., Al‐Windy, S., & Batiha, G. E. (2024) · Immunity Inflammation and Disease · doi:10.1002/iid3.1346 · Cited by 27
DNA sensors in metabolic and cardiovascular diseases: Molecular mechanisms and therapeutic prospects
Kwak, H., Lee, E., & Karki, R. (2024) · Immunological Reviews · doi:10.1111/imr.13382 · Cited by 27
“Metformin's ability to inhibit cell proliferation and migration of human aortic SMCs is diminished when IFI16 is silenced, 152,153 indicating IFI16's protective role against vascular remodeling and atherosclerosis (Figure 5B).”
Farbood, Y., Sarkaki, A., Khalaj, L., Khodagholi, F., Badavi, M., & Ashabi, G. (2015) · Microcirculation · doi:10.1111/micc.12224 · Cited by 27
Metabolic Homeostasis of Immune Cells Modulates Cardiovascular Diseases
Li, M., Sun, X., Zeng, L., Sun, A., & Ge, J. (2025) · Research · doi:10.34133/research.0679 · Cited by 26
“It is beneficial in attenuating atherosclerosis by reducing inflammation in the vessel wall [ 110 ].”
Defining the Role of Monocytes in Sjögren’s Syndrome
Sequí-Sabater, J. M., & Beretta, L. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232112765 · Cited by 26
Metadata
- Authors
- Vasamsetti, S. B., Karnewar, S., Kanugula, A. K., Thatipalli, A. R., Kumar, J. M., & Kotamraju, S.
- Affiliations
- Indian Institute of Chemical Technology (IN)
- Centre for Cellular and Molecular Biology (IN)
- Venue
- Diabetes
- Publisher
- American Diabetes Association
- Published
- 2014-12-31
- Volume
- 64
- Issue
- 6
- Pages
- 2028-2041
- ISSN
- 0012-1797 (ISSN-L)
- 1939-327X
- OpenAlex
- W2031565266
- Cited by
- 397
- References
- 32
- Citations by year
- 2026: 16 · 2025: 24 · 2024: 32 · 2023: 42 · 2022: 38 · 2021: 63 · 2020: 45 · 2019: 35 · 2018: 37 · 2017: 25 · 2016: 25 · 2015: 12
- FWCI
- 9.43
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Diabetes (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Science and Engineering Research Board (F.NO.SR/SO/HS-110/2008)
- Council for Scientific and Industrial Research (EpiHeD-BSC-0118, SMiLE-CSC-0111)
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › Atherosclerosis and Cardiovascular Diseases
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolism, Diabetes, and Cancer
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adipokines, Inflammation, and Metabolic Diseases
- Keywords
- metformin, monocyte-to-macrophage differentiation, AMPK, STAT3 phosphorylation, atherosclerosis, angiotensin II, inflammatory cytokines, c-Jun N-terminal kinase, aortic aneurysm, ApoE-deficient mice, AICAR, macrophage polarization, inflammation
- MeSH terms
- Animals, Apolipoproteins E, Cell Differentiation, Macrophages, Male, Metformin, Monocytes, Polymethacrylic Acids, Mice, Knockout, Atherosclerosis, STAT3 Transcription Factor, Mice, AMP-Activated Protein Kinases
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.